HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henry, R. R. Search for Related Content PubMed Articles by Henry, R. R. Social Bookmarking                What's this?

Preventing Cardiovascular Complications of Type 2 Diabetes: Focus on Lipid Management

IN BRIEF

Because type 2 diabetes can be considered a cardiovascular disease in its own right, current American Diabetes Association and National Cholesterol Education Program guidelines recommend aggressive treatment of dyslipidemia in people with diabetes, particularly for elevated LDL cholesterol levels. Use of appropriate treatment as determined by the pattern of lipid abnormalities can substantially reduce the risk of macrovascular disease. Institution of tight glycemic control will be beneficial to most patients, but the majority of people with diabetes will also require diet therapy, weight reduction when necessary, and intensive lipid-lowering therapy, which commonly involves one of the statins or fibric acid derivatives.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M McKenney Potential Nontraditional Applications of Statins Ann. Pharmacother., July 1, 2003; 37(7): 1063 - 1071. [Abstract] [Full Text] [PDF]

				J. Edelsberg, D. Weycker, and G. Oster Response to Lamotte et al. Diabetes Care, October 1, 2002; 25(10): 1899 - 1900. [Full Text]